Because Agfa-Gevaert still carries a shrinking traditional film business, its traditional film activities face pressure from declining medical film markets. A growing aging population drives imaging demand because elderly individuals are prone to conditions needing frequent MRI, CT, ultrasound, and X-ray procedures. Advances in AI-integrated imaging, 3D/4D imaging, and portable point-of-care devices improve diagnostic accuracy and workflow efficiency and lift adoption in hospitals and diagnostic centers; the Direct Radiography business grew 8% in 2024, stronger than the market.
Siemens Healthineers' Imaging segment recorded comparable revenue growth of 6.5% and an adjusted EBIT margin of 20.6%.
2Risk Factors
The pressure on traditional film activities from declining medical film markets could keep Agfa-Gevaert loss-making because it weighs on results alongside high restructuring expenses and adjustments tied to a Radiology Solutions impairment that yielded a 92 million euro net loss, while the cost-savings program and covenant headroom offer the main mitigants.
Adjustments and restructuring expenses created a 75 million euro charge, up from 39 million euro in 2023, while full year free cash flow reached minus 46 million euro despite a positive fourth-quarter figure of 35 million euro. At the close of the fourth quarter, net debt to adjusted EBITDA stood at 0.7 against a covenant maximum of 3, and a self-funding cost program targets 50 million euro in savings by the end of 2027 with initial savings anticipated in the second half of 2025.